Evidence map›Paper›PMID 40476123›Full record

ArticleCureus2025

Proton Beam Therapy for the Treatment of Recurrent Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma: A Case Report.

Ken Matsumoto, Shiro Akahani

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ken MatsumotoOtolaryngology - Head and Neck Surgery, Kansai Rosai Hospital, Amagasaki, JPN.
Shiro AkahaniOtolaryngology - Head and Neck Surgery, Kansai Rosai Hospital, Amagasaki, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human papillomavirus-related multiphenotypic sinonasal carcinoma (HMSC) is a rare sinonasal tract tumor. Although HMSC has a favorable prognosis, patients tend to experience local recurrence after the initial therapy; therefore, careful follow-up is required after surgical dissection. Proton beam therapy is one of the therapeutic modalities used to treat sinonasal cancer. This is the first report on the use of proton beam therapy for definitive irradiation in HMSC. Herein, we report the case of a 30-year-old woman with HMSC. The right nasal tumor was surgically resected by endoscopy, and HMSC was diagnosed using pathology. The diagnosis of HMSC was made. Nine months after surgery, a recurrent invasive tumor was found in the right nasal cavity, and surgical treatment was not feasible. Proton beam therapy was administered to the recurrent lesion, resulting in radiographic complete response maintained for nine months. This case suggests that postoperative recurrence must be noted and that proton beam therapy is an option to treat locally advanced lesions.

Indexed as

head and neckhmschpv-related multiphenotypic sinonasal carcinomalocal recurrenceproton beam therapysinonasal carcinoma

Identifiers

PMID40476123
PMCPMC12137199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.